
Retraction: Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer Cells
Author(s) -
PLOS ONE Editors
Publication year - 2020
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0244194
Subject(s) - doxorubicin , zoledronic acid , multiple drug resistance , cancer research , cancer cell , medicine , cancer , drug resistance , oncology , chemotherapy , biology , microbiology and biotechnology